Literature DB >> 16928839

Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants.

Raz Somech1, Guy Tal, Eli Gilad, Avigdor Mandelberg, Asher Tal, Ilan Dalal.   

Abstract

We prospectively quantified disease severity associated with epidemiologic and socioeconomic parameters as well as the clinical factors in 195 previously healthy infants with confirmed respiratory syncytial virus (RSV) infection. Infants were enrolled into three subgroups according to disease severity: outpatients (82 patients), inpatients (100 patients), and intensive care unit patients (13 patients). Epidemiologic parameters such as gestational age, birth weight, chronologic age at presentation, and gender as well as socioeconomic factors such as ethnic origin, family history of asthma, exposure to cigarette smoke, number of family members, presence of pets at home, breast-feeding, and day-care attendance were not found to predict the severity of RSV illness in previously healthy infants. Our results emphasize the complexity of predicting disease severity in previously healthy infants with RSV infection and suggest that other parameters such as host genetic background might explain the clinical variability.

Entities:  

Mesh:

Year:  2006        PMID: 16928839     DOI: 10.1177/0009922806291012

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  8 in total

1.  RSV infection among children born moderately preterm in a community-based cohort.

Authors:  Rolof G P Gijtenbeek; Jorien M Kerstjens; Sijmen A Reijneveld; Eric J Duiverman; Arend F Bos; Elianne J L E Vrijlandt
Journal:  Eur J Pediatr       Date:  2014-09-06       Impact factor: 3.183

2.  Low serum 25-hydroxyvitamin D levels and bronchiolitis severity in Spanish infants.

Authors:  Gloria Moreno-Solís; Fernando Fernández-Gutiérrez; Javier Torres-Borrego; Ricardo Torcello-Gáspar; José Luis Gómez-Chaparro Moreno; Juan Luis Pérez-Navero
Journal:  Eur J Pediatr       Date:  2014-09-02       Impact factor: 3.183

3.  Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan.

Authors:  Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; Pingsheng Wu; William D Dupont; Edward F Mitchel; Rachel Enriquez; Tina V Hartert
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 5.  Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children.

Authors:  Joseph R DiFranza; Anthony Masaquel; Amy M Barrett; Ann D Colosia; Parthiv J Mahadevia
Journal:  BMC Pediatr       Date:  2012-06-21       Impact factor: 2.125

Review 6.  Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials.

Authors:  Barbara Rath; Tim Conrad; Puja Myles; Maren Alchikh; Xiaolin Ma; Christian Hoppe; Franziska Tief; Xi Chen; Patrick Obermeier; Bron Kisler; Brunhilde Schweiger
Journal:  Expert Rev Anti Infect Ther       Date:  2017-05-12       Impact factor: 5.091

7.  Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy.

Authors:  Paola Di Carlo; Amelia Romano; Ludovico Salsa; Alessandra Gueli; Antonella Poma; Fortunata Fucà; Piera Dones; Mirella Collura; Diego Pampinella; Delia Motisi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2009-05-02       Impact factor: 2.638

8.  Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences.

Authors:  S Bosis; S Esposito; H G M Niesters; G V Zuccotti; G Marseglia; M Lanari; G Zuin; C Pelucchi; A D M E Osterhaus; N Principi
Journal:  Clin Microbiol Infect       Date:  2008-07       Impact factor: 8.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.